Research Analysts Set Expectations for Kura Oncology FY2030 Earnings
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Equities researchers at Brookline Capital Management issued their FY2030 earnings per share (EPS) estimates for Kura Oncology in a research note issued to investors on Monday, January 5th. Brookline Capital Management analyst L. Cann forecasts that t
Source link